Yr-ender 2024: Pharma takes pole place for 2025 race with 39% index returns, 9 multibaggers. Which shares to purchase?
Pharma sector is predicted to finish as the highest performer of 2024, carefully adopted by realty ...
Read morePharma sector is predicted to finish as the highest performer of 2024, carefully adopted by realty ...
Read moreThis text was written byObserveEdmund Ingham is a biotech guide. He has been protecting biotech, healthcare, ...
Read moreNEW DELHI: The Nifty Pharma index closed on a unfavorable notice on Monday. Shares of Natco ...
Read moreWithin the realm of life-saving improvements, the pharmaceutical sector stands as a beacon of hope. This ...
Read moreNEW DELHI: The Nifty Pharma index closed on a unfavourable notice on Tuesday. Shares of Natco ...
Read moreBrokerages comparable to Investec have a maintain and purchase ranking on HUL and Zensar Tech respectively, ...
Read moreMumbai: Hema CIPEF (I), an affiliate of the US-based Capital Group, is prone to promote a ...
Read moreBasic Evaluation of Solar Pharma: Solar Pharma is the most important pharma firm in India and ...
Read moreMankind Pharma on Tuesday reported 52% leap in internet revenue to Rs 294 crore in Q4FY23 ...
Read moreMartin Shkreli, the previous pharmaceutical chief government officer who served virtually seven years in jail for ...
Read more Copyright © 2022 - Newshare 24.
Newshare 24 is not responsible for the content of external sites.